Biosimilars for Management of Crohn Disease

Ole Haagen Nielsen; Mark Andrew Ainsworth

doi:10.7326/M18-3060

Biosimilars for Management of Crohn Disease

Ole Haagen Nielsen
, Mark Andrew Ainsworth

Afdeling for Mave-, Tarm- og Leversygdomme HGH

4 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Annals of Internal Medicine
Vol/bind	170
Udgave nummer	2
Sider (fra-til)	129-130
Antal sider	2
ISSN	0003-4819
DOI	https://doi.org/10.7326/M18-3060
Status	Udgivet - 15 jan. 2019

Adgang til dokumentet

10.7326/M18-3060

Citationsformater

@article{28682c511b9f417c82cdfb0f2da0704a,

title = "Biosimilars for Management of Crohn Disease",

keywords = "Biosimilar Pharmaceuticals/economics, Cost Savings, Crohn Disease/drug therapy, Drug Development/economics, European Union, Humans, Infliximab/therapeutic use, Prescription Fees, Tumor Necrosis Factor-alpha/antagonists \& inhibitors, United States",

author = "Nielsen, \{Ole Haagen\} and Ainsworth, \{Mark Andrew\}",

year = "2019",

month = jan,

day = "15",

doi = "10.7326/M18-3060",

language = "English",

volume = "170",

pages = "129--130",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "2",

}

TY - JOUR

T1 - Biosimilars for Management of Crohn Disease

AU - Nielsen, Ole Haagen

AU - Ainsworth, Mark Andrew

PY - 2019/1/15

Y1 - 2019/1/15

KW - Biosimilar Pharmaceuticals/economics

KW - Cost Savings

KW - Crohn Disease/drug therapy

KW - Drug Development/economics

KW - European Union

KW - Humans

KW - Infliximab/therapeutic use

KW - Prescription Fees

KW - Tumor Necrosis Factor-alpha/antagonists & inhibitors

KW - United States

U2 - 10.7326/M18-3060

DO - 10.7326/M18-3060

M3 - Journal article

C2 - 30535358

SN - 0003-4819

VL - 170

SP - 129

EP - 130

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 2

ER -